These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35056935)

  • 1. Zein-Based Nanoparticles as Oral Carriers for Insulin Delivery.
    Reboredo C; González-Navarro CJ; Martínez-López AL; Martínez-Ohárriz C; Sarmento B; Irache JM
    Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of PEG-coated zein nanoparticles for oral drug delivery purposes.
    Reboredo C; González-Navarro CJ; Martínez-Oharriz C; Martínez-López AL; Irache JM
    Int J Pharm; 2021 Mar; 597():120287. PubMed ID: 33524523
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Martínez-López AL; González-Navarro CJ; Aranaz P; Vizmanos JL; Irache JM
    Acta Pharm Sin B; 2021 Apr; 11(4):989-1002. PubMed ID: 33996411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zein-based nanocarriers for the oral delivery of insulin. In vivo evaluation in Caenorhabditis elegans.
    Martínez-López AL; González-Navarro CJ; Vizmanos JL; Irache JM
    Drug Deliv Transl Res; 2021 Apr; 11(2):647-658. PubMed ID: 33515186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of zein-based nanoparticles reduces glycemia and improves glucose tolerance in rats.
    Reboredo C; González-Navarro CJ; Martínez-López AL; Irache JM
    Int J Pharm; 2022 Nov; 628():122255. PubMed ID: 36191813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zein-based nanoparticles for the oral delivery of insulin.
    Inchaurraga L; Martínez-López AL; Martin-Arbella N; Irache JM
    Drug Deliv Transl Res; 2020 Dec; 10(6):1601-1611. PubMed ID: 32514704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the fate of zein nanoparticles by their coating with a Gantrez® AN-thiamine polymer conjugate.
    Inchaurraga L; Martínez-López AL; Abdulkarim M; Gumbleton M; Quincoces G; Peñuelas I; Martin-Arbella N; Irache JM
    Int J Pharm X; 2019 Dec; 1():100006. PubMed ID: 31517271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation, Characterisation and Evaluation of the Antihypertensive Peptides, Isoleucine-Proline-Proline and Leucine-Lysine-Proline in Chitosan Nanoparticles Coated with Zein for Oral Drug Delivery.
    Khalid Danish M; Gleeson JP; Brayden DJ; Byrne HJ; Frías JM; Ryan SM
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles from Gantrez-based conjugates for the oral delivery of camptothecin.
    Huarte J; Espuelas S; Martínez-Oharriz C; Irache JM
    Int J Pharm X; 2021 Dec; 3():100104. PubMed ID: 34825166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zein nanoparticles as oral carrier for mometasone furoate delivery.
    Zimath P; Pinto S; Dias S; Rafacho A; Sarmento B
    Drug Deliv Transl Res; 2023 Nov; 13(11):2948-2959. PubMed ID: 37208563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization and evaluation of zein nanoparticles to improve the oral delivery of glibenclamide. In vivo study using C. elegans.
    Lucio D; Martínez-Ohárriz MC; Jaras G; Aranaz P; González-Navarro CJ; Radulescu A; Irache JM
    Eur J Pharm Biopharm; 2017 Dec; 121():104-112. PubMed ID: 28986295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration.
    Inchaurraga L; Martín-Arbella N; Zabaleta V; Quincoces G; Peñuelas I; Irache JM
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):280-9. PubMed ID: 25541441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
    Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
    J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrophilic and Electroneutral Nanoparticles to Overcome Mucus Trapping and Enhance Oral Delivery of Insulin.
    Tan X; Yin N; Liu Z; Sun R; Gou J; Yin T; Zhang Y; He H; Tang X
    Mol Pharm; 2020 Sep; 17(9):3177-3191. PubMed ID: 32697099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucus-penetrating and permeation enhancer albumin-based nanoparticles for oral delivery of macromolecules: Application to bevacizumab.
    Pangua C; Espuelas S; Martínez-Ohárriz MC; Vizmanos JL; Irache JM
    Drug Deliv Transl Res; 2024 May; 14(5):1189-1205. PubMed ID: 37880504
    [TBL] [